Postcovid syndrome in the practice of a therapist
DOI: https://doi.org/10.29296/25877305-2022-04-03
Issue:
4
Year:
2022
Postcoid syndrome (post-COVID-19 syndrome, Long COVID, post-acute sequelae of COVID-19, PASC, chronic COVID syndrome, CCS, long-haul COVID) is a consequence of a new coronavirus infection (COVID-19), in which up to 20% of people who have had a coronavirus infection suffer from long-term symptoms lasting up to 12 weeks or longer. Postcoid syndrome is represented in ICD 10 by code U09.9 «Condition after COVID-19, unspecified.» There is no universal consensus on the definition of postcoid syndrome. Some authors suggest that the subacute period begins three weeks after the onset of symptoms, since the average duration of a positive polymerase chain reaction (PCR) in symptomatic patients is estimated at 24 days.
Keywords:
COVID-19
postcoid syndrome
systemic lesions
diagnostics
treatment
References:
- Escher F., Pietsch H., Aleshcheva G. et al. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail. 2020; 7 (5): 2440–7. DOI: 10.1002/ehf2.12805
- Chopra V., Flanders S.A., O’Malley M. et al. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2021; 174 (4): 576–8. DOI: 10.7326/M20-5661
- Arnold D.T., Hamilton F.W., Milne A. et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021; 76 (4): 399–401. DOI: 10.1136/thoraxjnl-2020-216086
- Wu Q., Zhou L., Sun X. et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci Rep. 2017; 7 (1): 9110. DOI: 10.1038/s41598-017-09536-z
- Chaudhary R., Kreutz R.P., Bliden K.P. et al. Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry. Thromb Haemost. 2020; 120 (11): 1594–6. DOI: 10.1055/s-0040-1714217
- Oronsky B., Larson C., Hammond T.C. et al. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2021; 1–9. [Epub ahead of print]. DOI: 10.1007/s12016-021-08848-3
- Salmon-Ceron D., Slama D., De Broucker T. et al. APHP COVID-19 research collaboration. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infect. 2021; 82: e1-4. DOI: 10.1016/j.jinf.2020.12.002
- Carmo A., Pereira-Vaz J., Mota V. et al. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID. J Med Virol. 2020; 92 (10): 2227–31. DOI: 10.1002/jmv.26103
- Kandetu T.B., Dziuban E.J., Sikuvi K. et al. Persistence of positive RT-PCR results for over 70 days in two travelers with COVID-19. Disaster Med Public Health Prep. 2020; 1–2. DOI:10.1017/dmp.2020.450
- Vibholm L.K., Nielsen S.S.F., Pahus M.H. et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021; 64: 103230. DOI: 10.1016/j.ebiom.2021.103230
- Wang X., Huang K., Jiang H. et al. Long-term existence of SARS-CoV-2 in COVID-19 patients: host immunity, viral virulence, and transmissibility. Virol Sin. 2020; 35 (6): 793–802. DOI: 10.1007/s12250-020-00308-0
- Kudlay D., Shirobokov Ya., Gladunova E. et al. Diagnosis of COVID-19. Methods and problems of virus SARS-CoV-2 detection under pandemic conditions. Vrach. 2020; 31 (8): 5–10 (in Russ.). DOI: 10.29296/25877305-2020-08-01
- Hirotsu Y., Maejima M., Shibusawa M. et al. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection. J Infect Chemother. 2020; 27 (2): 406–9. DOI: 10.1016/j.jiac.2020.10.026
- Li Q., Zheng X.S., Shen X.R. et al. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19. Emerg Microbes Infect. 2020; 9 (1): 2571–7. DOI: 10.1080/22221751.2020.1852058
- Park S.K., Lee C., Park D. et al. Detection of SARS-CoV-2 in fecal samples from patients with asymptomatic and mild COVID-19 in Korea. Clin Gastroenterol Hepatol. 2020; 19 (7): 1387–94.e2. DOI: 10.1016/j.cgh.2020.06.005
- Wu Y., Guo C., Tang L. et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020; 5 (5): 434–5. DOI: 10.1016/S2468-1253(20)30083-2
- Gaebler C., Wang Z., Lorenz J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021; 591 (7851): 639–44. DOI: 10.1038/s41586-021-03207-w
- Ehrenfeld M., Tincani A., Andreoli L. et al. COVID-19 and autoimmunity. Autoimmun Rev. 2020; 19 (8): 102597. DOI: 10.1016/j.autrev.2020.102597
- Lui D.T.W., Lee C.H., Chow W.S. et al. Thyroid dysfunction in relation to immune profile, disease status and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2020; 106 (2): e926–e935. DOI: 10.1210/clinem/dgaa813
- Muller I., Cannavaro D., Dazzi D. et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020; 8 (9): 739–41. DOI: 10.1016/S2213-8587(20)30266-7
- Li Q., Wang B., Mu K. et al. The pathogenesis of thyroid autoimmune diseases: New T lymphocytes – Cytokines circuits beyond the Th1-Th2 paradigm. J Cell Physiol. 2019; 234 (3): 2204–16. DOI: 10.1002/jcp.27180
- Zuo Y., Estes S.K., Ali R.A. et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020; 12: eabd3876. DOI: 10.1126/scitranslmed.abd3876
- Bastard P., Rosen L.B., Zhang Q. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020; 370 (6515): 370. DOI: 10.1126/science.abd4585
- Gao Z.W., Zhang H., Liu C. et al. Autoantibodies in COVID-19: frequency and function. Autoimmun Rev. 2021; 20 (3): 102754. DOI: 10.1016/j.autrev.2021.102754
- Vlachoyiannopoulos P.G., Magira E., Alexopoulos H. et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020; 79 (12): 1661–3. DOI: 10.1136/annrheumdis-2020-218009
- Zhou Y., Han T., Chen J. et al. Clinical and autoimmune characteristics of severe and critical cases of COVID. Clin Transl Sci. 2020; 13 (6): 1077–86. DOI: 10.1111/cts.12805
- Elkon K., Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol. 2008; 4 (9): 491–8. DOI: 10.1038/ncprheum0895
- Cojocaru M., Cojocaru I.M., Silosi I. et al. Manifestations of systemic lupus erythematosus. Maedica (Bucur). 2011; 6 (4): 330–6.
- Guo Q., Wang Y., Xu D. et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018; 6: 15. DOI: 10.1038/s41413-018-0016-9
- Fathi N., Rezaei N. Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int. 2020; 44 (9): 1792–7. DOI: 10.1002/cbin.11403
- Tavakolpour S., Rakhshandehroo T., Wei E.X. et al. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol Lett. 2020; 225: 31–2. DOI: 10.1016/j.imlet.2020.06.013
- Cheng Y., Zhao H., Song P. et al. Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A. J Infect Public Health. 2019; 12 (6): 878–83. DOI: 10.1016/j.jiph.2019.05.017
- Kong M., Zhang H., Cao X. et al. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiol Infect. 2020; 148: e139. DOI: 10.1017/S0950268820001557
- Danwang C., Endomba F.T., Nkeck J.R. et al. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res. 2020; 8 (1): 37. DOI: 10.1186/s40364-020-00217-0
- Malik P., Patel U., Mehta D. et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2020; 26 (3): 107–8. DOI:10.1136/bmjebm-2020-111536
- Ou M., Zhu J., Ji P. et al. Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiol Infect. 2020; 148: e175. DOI: 10.1017/S095026882000179X
- Hu F., Chen F., Ou Z. et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol Immunol. 2020; 17 (11): 1119–25. DOI: 10.1038/s41423-020-00550-2
- Lamers M.M., Beumer J., Vaart J. et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020; 369 (6499): 50–4. DOI: 10.1126/science.abc1669
- Xiao F., Tang M., Zheng X. et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020; 158 (6): 1831–1833.e3. DOI: 10.1053/j.gastro.2020.02.055
- Zang R., Castro M.F.G., McCune B.T. et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020; 5 (47): eabc3582. DOI: 10.1126/sciimmunol.abc3582
- Cheung K.S., Hung I.F.N., Chan P.P.Y. et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong Cohort: systematic review and meta-analysis. Gastroenterology. 2020; 159 (1): 81–95. DOI: 10.1053/j.gastro.2020.03.065
- Mao R., Qiu Y., He J.S. et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020; 5 (7): 667–8. DOI: 10.1016/S2468-1253(20)30126-6
- Liang L., Yang B., Jiang N. et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci. 2020; 35 (47): e418. DOI: 10.3346/jkms.2020.35.e418
- Petersen M.S., Kristiansen M.F., Hanusson K.D. et al. Long COVID in the Faroe Islands – a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2021; 73 (11): e4058–e4063. DOI: 10.1093/cid/ciaa1792
- Zhao Y.M., Shang Y.M., Song W.B. et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020; 25: 100463. DOI: 10.1016/j.eclinm.2020.100463
- Yeoh Y.K., Zuo T., Lui G.C.-Y. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021; 70 (4): 698–706. DOI: 10.1136/gutjnl-2020-323020
- Zuo T., Zhan H., Zhang F. et al. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Gastroenterology. 2020; 159 (4): 1302–1310.e5. DOI: 10.1053/j.gastro.2020.06.048
- Zuo T., Zhang F., Lui G.C.Y. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020; 159 (3): 944–955.e8. DOI: 10.1053/j.gastro.2020.05.048
- Belkaid Y., Hand T.W. Role of the microbiota in immunity and inflammation. Cell. 2014; 157 (1): 121–50. DOI: 10.1016/j.cell.2014.03.011
- Yong S.J., Tong T., Chew J. et al. Antidepressive mechanisms of probiotics and their therapeutic potential. Front Neurosci. 2019; 13: 1361. DOI: 10.3389/fnins.2019.01361
- Williamson E.J., Walker A.J., Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020; 584 (7821): 430–6. DOI: 10.1038/s41586-020-2521-4
- Huang C., Huang L., Wang Y. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397 (10270): 220–32. DOI: 10.1016/S0140-6736(20)32656-8
- Borodulina E.A., Shirobokov Y.E., Gladunova E.P. et al. Virus-associated lung disease. Klinicheskaya farmakologiya i terapiya = Clin Pharmacol Ther. 2020; 29 (3): 61–6 (in Russ.). DOI: 10.32756/0869-5490-2020-3-61-66
- Burnham E.L., Janssen W.J., Riches D.W. et alP. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J. 2014; 43 (1): 276–85. DOI: 10.1183/09031936.00196412
- Ackermann M., Verleden S.E., Kuehnel M. et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N Engl J Med. 2020; 383 (2): 120–8. DOI: 10.1056/NEJMoa2015432
- Chippa V., Aleem A., Anjum F. Post Acute Coronavirus (COVID-19) Syndrome. [Updated 2021 Oct 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021.
- Lindner D., Fitzek A., Bräuninger H. et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020; 5 (11): 1281–5. DOI: 10.1001/jamacardio.2020.3551
- Solomon I.H., Normandin E., Bhattacharyya S. et al. Neuropathological Features of COVID-19. N Engl J Med. 2020; 383 (10): 989–92. DOI: 10.1056/NEJMc2019373
- Peleg Y., Kudose S., D’Agati V. et al. Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection. Kidney Int Rep. 2020; 5 (6): 940–5. DOI: 10.1016/j.ekir.2020.04.017
- Kaseda E.T., Levine A.J. Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. Clin Neuropsychol. 2020; 34 (7–8): 1498–514. DOI: 10.1080/13854046.2020.1811894
- Mo X., Jian W., Su Z. et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020; 55: 2001217. DOI: 10.1183/13993003.01217-2020
- Shah A.S., Wong A.W., Hague C.J. et al. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021; 76: 402–4. DOI: 10.1136/thoraxjnl-2020-216308
- Carvalho-Schneider C., Laurent E., Lemaignen A. et al. Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset. Clin Microbiol Infect. 2021; 27: 258–63. DOI: 10.1016/j.cmi.2020.09.052
- Carfi A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID19. JAMA. 2020; 324: 603–5. DOI: 10.1001/jama.2020.12603
- Nalbandian A., Sehgal K., Gupta A. et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27: 601–15. DOI: 10.1038/s41591-021-01283-z
- Puntmann V.O., Carerj M.L., Wieters I. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5: 1265–73. DOI: 10.1001/jamacardio.2020.3557
- Patell R., Bogue T., Koshy A. et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020; 136: 1342–6. DOI: 10.1182/blood.2020007938
- Taquet M., Geddes J.R., Husain M. et al. 6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8 (5): 416–27. DOI: 10.1016/S2215-0366(21)00084-5
- Sampaio Rocha-Filho P.A., Voss L. Persistent headache and persistent anosmia associated with COVID-19. Headache. 2020; 60: 1797–9. DOI: 10.1111/head.13941
- Liu J.W.T.W., de Luca R.D., Mello Neto H.O. et al. Post- COVID-19 syndrome? New daily persistent headache in the aftermath of COVID-19. Arq Neuropsiquiatr. 2020; 78 (11): 753–4. DOI: 10.1590/0004-282X20200187
- Dani M., Dirksen A., Taraborrelli P. et al. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies. Clin Med (Lond). 2021; 21 (1): e63–7. DOI: 10.7861/clinmed.2020-0896
- Dedov D. New coronavirus infection: clinical and pathogenetic aspects, prevention, importance of vitamins and trace elements. Vrach. 2022; 33 (2): 47–49 (in Russ.). DOI: 10.29296/25877305-2022-02-07
- Dedov D.V., Marchenko S.D. Vitamins, iron, zinc, selenium, selenium-containing drugs in the complex prevention of complications and treatment of patients with COVID-19. Pharmacy. 2022; 71 (1): 5–9. DOI: 10.29296/25419218-2022-01-01